Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rizobacter Argentina S.A. Interim / Quarterly Report 2019

Mar 14, 2019

68520_rns_2019-03-14_81c9dd27-eddb-4b45-bdf0-2e003ff88567.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

(Registration Number 2015 / 308733 / 07) Management Statements for the 6 month period ended 31 December 2018

Compiled Financial Statements

in compliance with Companies Act 71 of 2008

(Registration Number 2015 / 308733 / 07) Management Statements for the 6 month period ended 31 December 2018

Index

The reports and statements set out below comprise the financial statements presented to the shareholders:

General Information 2
Report of the Compiler 3
Statement of Financial Position 4
Statement of Comprehensive Income 5
Statement of Changes in Equity 6
Statement of Cash Flows 7
Supplementary information:
Detailed Income Statement
8

(Registration Number 2015 / 308733 / 07) Management Statements for the 6 month period ended 31 December 2018

General Information Country of Incorporation and Domicile South Africa Nature of Business and Principal Activities Agriculture Directors AG Lehmann PE Mac Mullen Registered Office 510 Makou Street Monument Park x 2 Pretoria Gauteng 0181 Business Address 510 Makou Street Monument Park x 2 Pretoria Gauteng 0181 Bankers The Standard Bank of South Africa Limited Compiler Chanette Haasbroek CA(SA) 6 Thorny Bush Place Moreleta Park Pretoria Gauteng 0042

(Registration Number 2015 / 308733 / 07)

Management Statements for the 6 month period ended 31 December 2018

Statement of Financial Position

Figures in R 31 December 2018 30 June 2018
1.
Assets
Non-Current Assets
Property, plant and equipment 149,139 198,438
Current Assets
Trade and other receivables 105,496 403,968
Cash and cash equivalents 131,079 76,378
236,575 480,346
Total Assets 385,714 678,784
2. Equity and Liabilities
Equity
Issued capital 120,000 120,000
(Accumulated loss) / retained earnings (268,844) 6,801
(148,844) 126,801
Non-Current Liabilities
Loans from shareholders 20,000 20,000
Current Liabilities
Trade and other payables 1,664 50,786
Loans from shareholders 512,894 481,197
514,558 531,983
Total Equity and Liabilities 385,714 678,784

(Registration Number 2015 / 308733 / 07)

Management Statements for the 6 month period ended 31 December 2018

Statement of Comprehensive Income 6 months
Figures in R 31 December 2018 30 June 2018
Revenue 13,043 557,261
Other income 4,821 -
Operating costs (285,349) (531,173)
Operating (loss)/profit (267,485) 26,088
Finance costs (8,160) (14,680)
(Loss)/profit for the year (275,645) 11,408

(Registration Number 2015 / 308733 / 07)

Management Statements for the 6 month period ended 31 December 2018

Statement of Changes in Equity

Accumulated
Figures in R Share capital loss Total
Balance at 1 July 2017 120,000 (4,607) 115,393
Total comprehensive income for the year
Profit for the year 11,408 11,408
Total comprehensive income for the year - 11,408 11,408
Balance at 30 June 2018 120,000 6,801 126,801
Balance at 1 July 2018 120,000 6,801 126,801
Total comprehensive income for the year
Loss for the year (275,645) (275,645)
Total comprehensive income for the year - (275,645) (275,645)
Balance at 31 December 2018 120,000 (268,844) (148,844)

(Registration Number 2015 / 308733 / 07)

Management Statements for the 6 month period ended 31 December 2018

Statement of Cash Flows 6 months
Figures in R 31 December 2018 30 June 2018
Cash flows from / (used in) operating activities
(Loss)/profit for the year (275,645) 11,408
Adjustments for:
Finance costs 8,160 14,680
Depreciation of property, plant and equipment 49,300 98,600
Operating cash flow before working capital changes (218,185) 124,688
Working capital changes
Decrease/(increase) in trade and other receivables 298,472 (320,854)
Decrease in short term loans 31,697 38,096
(Decrease)/increase in trade and other payables (49,123) 48,886
Net cash flows from / (used in) operations 62,861 (109,184)
Finance costs (8,160) (14,680)
Net cash flows from / (used in) operating activities 54,701 (123,864)
Net increase / (decrease) in cash and cash equivalents 54,701 (123,864)
Cash and cash equivalents at beginning of the year 76,378 200,242
Cash and cash equivalents at end of the year 131,079 76,378

(Registration Number 2015 / 308733 / 07)

Management Statements for the 6 month period ended 31 December 2018

Detailed Income Statement 6 months
Figures in R 31 December 2018 30 June 2018
Gross Revenue
Consulting fee income - 274,177
Lab analyses 13,043 -
Market development - 283,084
13,043 557,261
Other Income
Profit on foreign exchange 4,821 -
4,821 -
17,864 557,261
Expenditure
Accounting fees 53,407 36,202
Bank charges 2,415 3,040
Computer expenses 2,986 3,067
Consulting fees 44,041 27,554
Depreciation - Tangible assets 49,300 98,600
Electricity and water 8,049 17,769
Field and Greenhouse trials 50,000 132,953
Finance costs 8,160 14,680
Insurance 12,484 24,952
Lease rental on operating lease 52,868 105,420
Legal expense - 1,710
Logistics: Samples and others 3,510 5,084
Loss on foreign exchange - 32,764
Marketing - 3,175
Motor vehicle expense 955 1,873
Projects - 25,080
SABO Membership fees - 5,000
Secretarial fees 100 160
Telephone and internet 5,234 6,770
293,509 545,853
(Loss)/profit for the year (275,645) 11,408